GeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease Dataset

STAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) -- GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with Komodo Health, a premier healthcare technology company for the pharmaceutical industry. The new partnership will increase access to GeneDx's extensive de-identified rare disease data set, now available through Komodo Health's MapEnhance offering, including data from more than 500,000 exomes, enabling biopharma companie ...